02:49 PM EDT, 07/30/2026 (MT Newswires) -- (Updates with the latest stock movement in the first paragraph and headline.)

Regeneron Pharmaceuticals ( REGN ) shares were up over 5% in Thursday trading after the company reported higher Q2 results.

The company reported Q2 adjusted earnings Thursday of $14.29 per diluted share, up from $12.89 a year earlier.

Analysts polled by FactSet expected $10.16.

Revenue for the quarter ended June 30 was $4.29 billion, up from $3.68 billion a year earlier.

Analysts expected $3.82 billion.

Price: 728.81, Change: +33.39, Percent Change: +4.80